Navigation Sciences, Inc.

Brookline, MA · Medtech · Private

Real-time surgical navigation system using active sensing markers to localize lung tumors and assess resection margins during cancer surgery

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: Brookline, MA
Total capital: $701K

Federal grants: $701K; 3 awards · 2021–2025; Rank in peer group#27 of 445
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 4; 4 pending · first 2022; Rank in peer group#49 of 445

Capital timeline

Latest events

Sep 2025Federal grantHealth and Human S · Phase I · Targeted Localization and Optimized Surgical Resection for Lung Cancer$225K
Aug 2022Federal grantHealth and Human S · Phase I · Bronchoscopic lung navigation system for accurately excising lung nodules$76K
Sep 2021Federal grantHealth and Human S · Phase I · Bronchoscopic lung navigation system for accurately excising lung nodules$400K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

Federal grants#27 · top 6%
Granted patents#49 · top 11%
Linked publications#10 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 4 granted of 8

Apr 23, 2026PendingSystem And Method For Percutaneous Deployment Of SensorsUSPTOApplication 19161145
Feb 10, 2026GrantedSystem And Method For A Tissue Resection Margin Measurement DeviceUSPTOUS 12,544,105
Jan 20, 2026GrantedSystem For A Tissue Resection Margin Measurement DeviceUSPTOUS 12,527,599

Show all 8 patent records

System And Method For Percutaneous Deployment Of SensorsApr 23, 2026 · Application 19161145Pending
System And Method For A Tissue Resection Margin Measurement DeviceFeb 10, 2026 · US 12,544,105Granted
System For A Tissue Resection Margin Measurement DeviceJan 20, 2026 · US 12,527,599Granted
System And Method For A Tissue Resection Margin Measurement DeviceJan 6, 2026 · US 12,514,497Granted
System And Method For A Tissue Resection Margin Measurement DeviceJun 8, 2023 · Application 18081367Pending
System And Method For A Tissue Resection Margin Measurement DeviceFeb 1, 2022 · US 11,234,732Granted
System And Method For A Tissue Resection Margin Measurement DeviceApplication 63534915Pending
System And Method For A Tissue Resection Margin Measurement DeviceApplication PCTUS2020056114Pending

Recent research by its founders

Error-State Model Predictive Path Integral Control of Tendon-Driven Continuum Robots Using Cosserat Rod Dynamics With Strain Parametrization20260 cites
Few-Shot Physics-Informed Neural Network for Shape Reconstruction of Concentric-Tube Robots20260 cites
Deep Koopman Approach for Nonlinear Dynamics and Control of Tendon-Driven Continuum Robots20253 cites

EternaTear, Inc.Similar federal contract value in Medtech · null in contracts
PathRight Medical Inc.Similar federal contract value in Medtech · null in contracts
Prana Thoracic, Inc.Similar federal contract value in Medtech · null in contracts
LIGHT AGE, INC.Similar federal contract value in Medtech · null in contracts
IdentifySensors Biologics Corp.Similar federal contract value in Medtech · null in contracts
Ni2o, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.